6SLN-lipo PGA specifically catches (coats) human influenza virus and synergizes neuraminidase-targeting drugs for human influenza therapeutic potential.
Identifieur interne : 000C22 ( Main/Exploration ); précédent : 000C21; suivant : 000C236SLN-lipo PGA specifically catches (coats) human influenza virus and synergizes neuraminidase-targeting drugs for human influenza therapeutic potential.
Auteurs : Nongluk Sriwilaijaroen [Oman] ; Katsuhiko Suzuki [Japon] ; Emi Takashita [Japon] ; Hiroaki Hiramatsu [Japon] ; Osamu Kanie [Japon] ; Yasuo Suzuki [Japon]Source :
- The Journal of antimicrobial chemotherapy [ 1460-2091 ] ; 2015.
Descripteurs français
- KwdFr :
- Acide polyglutamique (), Acide polyglutamique (analogues et dérivés), Acide polyglutamique (pharmacologie), Acide polyglutamique (synthèse chimique), Animaux, Antienzymes (pharmacologie), Antiviraux (), Antiviraux (pharmacologie), Antiviraux (synthèse chimique), Attachement viral (), Concentration inhibitrice 50, Glycolipides (), Glycolipides (pharmacologie), Glycolipides (synthèse chimique), Humains, Liaison aux protéines, Lignée cellulaire, Protéines virales (antagonistes et inhibiteurs), Relation dose-effet des médicaments, Récepteurs viraux (métabolisme), Sialidase (antagonistes et inhibiteurs), Synergie des médicaments, Virus de la grippe A (), Virus de la grippe A (physiologie), Érythrocytes (), Érythrocytes (virologie).
- MESH :
- analogues et dérivés : Acide polyglutamique.
- antagonistes et inhibiteurs : Protéines virales, Sialidase.
- métabolisme : Récepteurs viraux.
- pharmacologie : Acide polyglutamique, Antienzymes, Antiviraux, Glycolipides.
- physiologie : Virus de la grippe A.
- synthèse chimique : Acide polyglutamique, Antiviraux, Glycolipides.
- virologie : Érythrocytes.
- Acide polyglutamique, Animaux, Antiviraux, Attachement viral, Concentration inhibitrice 50, Glycolipides, Humains, Liaison aux protéines, Lignée cellulaire, Relation dose-effet des médicaments, Synergie des médicaments, Virus de la grippe A, Érythrocytes.
English descriptors
- KwdEn :
- Animals, Antiviral Agents (chemical synthesis), Antiviral Agents (chemistry), Antiviral Agents (pharmacology), Cell Line, Dose-Response Relationship, Drug, Drug Synergism, Enzyme Inhibitors (pharmacology), Erythrocytes (drug effects), Erythrocytes (virology), Glycolipids (chemical synthesis), Glycolipids (chemistry), Glycolipids (pharmacology), Humans, Influenza A virus (drug effects), Influenza A virus (physiology), Inhibitory Concentration 50, Neuraminidase (antagonists & inhibitors), Polyglutamic Acid (analogs & derivatives), Polyglutamic Acid (chemical synthesis), Polyglutamic Acid (chemistry), Polyglutamic Acid (pharmacology), Protein Binding, Receptors, Virus (metabolism), Viral Proteins (antagonists & inhibitors), Virus Attachment (drug effects).
- MESH :
- chemical , analogs & derivatives : Polyglutamic Acid.
- chemical , antagonists & inhibitors : Neuraminidase, Viral Proteins.
- chemical , chemical synthesis : Antiviral Agents, Glycolipids, Polyglutamic Acid.
- chemical , chemistry : Antiviral Agents, Glycolipids, Polyglutamic Acid.
- chemical , metabolism : Receptors, Virus.
- chemical , pharmacology : Antiviral Agents, Enzyme Inhibitors, Glycolipids, Polyglutamic Acid.
- drug effects : Erythrocytes, Influenza A virus, Virus Attachment.
- physiology : Influenza A virus.
- virology : Erythrocytes.
- Animals, Cell Line, Dose-Response Relationship, Drug, Drug Synergism, Humans, Inhibitory Concentration 50, Protein Binding.
Abstract
The purpose of this study was to develop a new compound to overcome influenza epidemics and pandemics as well as drug resistance.
DOI: 10.1093/jac/dkv193
PubMed: 26169554
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000635
- to stream PubMed, to step Curation: 000635
- to stream PubMed, to step Checkpoint: 000700
- to stream Ncbi, to step Merge: 001A51
- to stream Ncbi, to step Curation: 001A51
- to stream Ncbi, to step Checkpoint: 001A51
- to stream Main, to step Merge: 000C26
- to stream Main, to step Curation: 000C22
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">6SLN-lipo PGA specifically catches (coats) human influenza virus and synergizes neuraminidase-targeting drugs for human influenza therapeutic potential.</title><author><name sortKey="Sriwilaijaroen, Nongluk" sort="Sriwilaijaroen, Nongluk" uniqKey="Sriwilaijaroen N" first="Nongluk" last="Sriwilaijaroen">Nongluk Sriwilaijaroen</name><affiliation wicri:level="1"><nlm:affiliation>Department of Preclinical Sciences, Faculty of Medicine, Thammasat University (Rangsit Campus), Pathumthani 12120, Thailand College of Life and Health Sciences, Chubu University, Aichi 487-8501, Japan snongluk@hotmail.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Department of Preclinical Sciences, Faculty of Medicine, Thammasat University (Rangsit Campus), Pathumthani 12120, Thailand College of Life and Health Sciences, Chubu University, Aichi 487-8501</wicri:regionArea><wicri:noRegion>Aichi 487-8501</wicri:noRegion></affiliation></author><author><name sortKey="Suzuki, Katsuhiko" sort="Suzuki, Katsuhiko" uniqKey="Suzuki K" first="Katsuhiko" last="Suzuki">Katsuhiko Suzuki</name><affiliation wicri:level="1"><nlm:affiliation>Synthetic Cellular Chemistry Laboratory, RIKEN, Saitama 351-0198, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Synthetic Cellular Chemistry Laboratory, RIKEN, Saitama 351-0198</wicri:regionArea><wicri:noRegion>Saitama 351-0198</wicri:noRegion></affiliation></author><author><name sortKey="Takashita, Emi" sort="Takashita, Emi" uniqKey="Takashita E" first="Emi" last="Takashita">Emi Takashita</name><affiliation wicri:level="1"><nlm:affiliation>Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo 208-0011</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement><region type="région">Région de Kantō</region></placeName></affiliation></author><author><name sortKey="Hiramatsu, Hiroaki" sort="Hiramatsu, Hiroaki" uniqKey="Hiramatsu H" first="Hiroaki" last="Hiramatsu">Hiroaki Hiramatsu</name><affiliation wicri:level="1"><nlm:affiliation>College of Life and Health Sciences, Chubu University, Aichi 487-8501, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>College of Life and Health Sciences, Chubu University, Aichi 487-8501</wicri:regionArea><wicri:noRegion>Aichi 487-8501</wicri:noRegion></affiliation></author><author><name sortKey="Kanie, Osamu" sort="Kanie, Osamu" uniqKey="Kanie O" first="Osamu" last="Kanie">Osamu Kanie</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Glycoscience, Tokai University, Kanagawa 259-1292, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Institute of Glycoscience, Tokai University, Kanagawa 259-1292</wicri:regionArea><wicri:noRegion>Kanagawa 259-1292</wicri:noRegion></affiliation></author><author><name sortKey="Suzuki, Yasuo" sort="Suzuki, Yasuo" uniqKey="Suzuki Y" first="Yasuo" last="Suzuki">Yasuo Suzuki</name><affiliation wicri:level="1"><nlm:affiliation>College of Life and Health Sciences, Chubu University, Aichi 487-8501, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>College of Life and Health Sciences, Chubu University, Aichi 487-8501</wicri:regionArea><wicri:noRegion>Aichi 487-8501</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26169554</idno><idno type="pmid">26169554</idno><idno type="doi">10.1093/jac/dkv193</idno><idno type="wicri:Area/PubMed/Corpus">000635</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000635</idno><idno type="wicri:Area/PubMed/Curation">000635</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000635</idno><idno type="wicri:Area/PubMed/Checkpoint">000700</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000700</idno><idno type="wicri:Area/Ncbi/Merge">001A51</idno><idno type="wicri:Area/Ncbi/Curation">001A51</idno><idno type="wicri:Area/Ncbi/Checkpoint">001A51</idno><idno type="wicri:Area/Main/Merge">000C26</idno><idno type="wicri:Area/Main/Curation">000C22</idno><idno type="wicri:Area/Main/Exploration">000C22</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">6SLN-lipo PGA specifically catches (coats) human influenza virus and synergizes neuraminidase-targeting drugs for human influenza therapeutic potential.</title><author><name sortKey="Sriwilaijaroen, Nongluk" sort="Sriwilaijaroen, Nongluk" uniqKey="Sriwilaijaroen N" first="Nongluk" last="Sriwilaijaroen">Nongluk Sriwilaijaroen</name><affiliation wicri:level="1"><nlm:affiliation>Department of Preclinical Sciences, Faculty of Medicine, Thammasat University (Rangsit Campus), Pathumthani 12120, Thailand College of Life and Health Sciences, Chubu University, Aichi 487-8501, Japan snongluk@hotmail.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Department of Preclinical Sciences, Faculty of Medicine, Thammasat University (Rangsit Campus), Pathumthani 12120, Thailand College of Life and Health Sciences, Chubu University, Aichi 487-8501</wicri:regionArea><wicri:noRegion>Aichi 487-8501</wicri:noRegion></affiliation></author><author><name sortKey="Suzuki, Katsuhiko" sort="Suzuki, Katsuhiko" uniqKey="Suzuki K" first="Katsuhiko" last="Suzuki">Katsuhiko Suzuki</name><affiliation wicri:level="1"><nlm:affiliation>Synthetic Cellular Chemistry Laboratory, RIKEN, Saitama 351-0198, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Synthetic Cellular Chemistry Laboratory, RIKEN, Saitama 351-0198</wicri:regionArea><wicri:noRegion>Saitama 351-0198</wicri:noRegion></affiliation></author><author><name sortKey="Takashita, Emi" sort="Takashita, Emi" uniqKey="Takashita E" first="Emi" last="Takashita">Emi Takashita</name><affiliation wicri:level="1"><nlm:affiliation>Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo 208-0011</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement><region type="région">Région de Kantō</region></placeName></affiliation></author><author><name sortKey="Hiramatsu, Hiroaki" sort="Hiramatsu, Hiroaki" uniqKey="Hiramatsu H" first="Hiroaki" last="Hiramatsu">Hiroaki Hiramatsu</name><affiliation wicri:level="1"><nlm:affiliation>College of Life and Health Sciences, Chubu University, Aichi 487-8501, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>College of Life and Health Sciences, Chubu University, Aichi 487-8501</wicri:regionArea><wicri:noRegion>Aichi 487-8501</wicri:noRegion></affiliation></author><author><name sortKey="Kanie, Osamu" sort="Kanie, Osamu" uniqKey="Kanie O" first="Osamu" last="Kanie">Osamu Kanie</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Glycoscience, Tokai University, Kanagawa 259-1292, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Institute of Glycoscience, Tokai University, Kanagawa 259-1292</wicri:regionArea><wicri:noRegion>Kanagawa 259-1292</wicri:noRegion></affiliation></author><author><name sortKey="Suzuki, Yasuo" sort="Suzuki, Yasuo" uniqKey="Suzuki Y" first="Yasuo" last="Suzuki">Yasuo Suzuki</name><affiliation wicri:level="1"><nlm:affiliation>College of Life and Health Sciences, Chubu University, Aichi 487-8501, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>College of Life and Health Sciences, Chubu University, Aichi 487-8501</wicri:regionArea><wicri:noRegion>Aichi 487-8501</wicri:noRegion></affiliation></author></analytic><series><title level="j">The Journal of antimicrobial chemotherapy</title><idno type="eISSN">1460-2091</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antiviral Agents (chemical synthesis)</term><term>Antiviral Agents (chemistry)</term><term>Antiviral Agents (pharmacology)</term><term>Cell Line</term><term>Dose-Response Relationship, Drug</term><term>Drug Synergism</term><term>Enzyme Inhibitors (pharmacology)</term><term>Erythrocytes (drug effects)</term><term>Erythrocytes (virology)</term><term>Glycolipids (chemical synthesis)</term><term>Glycolipids (chemistry)</term><term>Glycolipids (pharmacology)</term><term>Humans</term><term>Influenza A virus (drug effects)</term><term>Influenza A virus (physiology)</term><term>Inhibitory Concentration 50</term><term>Neuraminidase (antagonists & inhibitors)</term><term>Polyglutamic Acid (analogs & derivatives)</term><term>Polyglutamic Acid (chemical synthesis)</term><term>Polyglutamic Acid (chemistry)</term><term>Polyglutamic Acid (pharmacology)</term><term>Protein Binding</term><term>Receptors, Virus (metabolism)</term><term>Viral Proteins (antagonists & inhibitors)</term><term>Virus Attachment (drug effects)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Acide polyglutamique ()</term><term>Acide polyglutamique (analogues et dérivés)</term><term>Acide polyglutamique (pharmacologie)</term><term>Acide polyglutamique (synthèse chimique)</term><term>Animaux</term><term>Antienzymes (pharmacologie)</term><term>Antiviraux ()</term><term>Antiviraux (pharmacologie)</term><term>Antiviraux (synthèse chimique)</term><term>Attachement viral ()</term><term>Concentration inhibitrice 50</term><term>Glycolipides ()</term><term>Glycolipides (pharmacologie)</term><term>Glycolipides (synthèse chimique)</term><term>Humains</term><term>Liaison aux protéines</term><term>Lignée cellulaire</term><term>Protéines virales (antagonistes et inhibiteurs)</term><term>Relation dose-effet des médicaments</term><term>Récepteurs viraux (métabolisme)</term><term>Sialidase (antagonistes et inhibiteurs)</term><term>Synergie des médicaments</term><term>Virus de la grippe A ()</term><term>Virus de la grippe A (physiologie)</term><term>Érythrocytes ()</term><term>Érythrocytes (virologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Polyglutamic Acid</term></keywords><keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Neuraminidase</term><term>Viral Proteins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Antiviral Agents</term><term>Glycolipids</term><term>Polyglutamic Acid</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Antiviral Agents</term><term>Glycolipids</term><term>Polyglutamic Acid</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Receptors, Virus</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term><term>Enzyme Inhibitors</term><term>Glycolipids</term><term>Polyglutamic Acid</term></keywords><keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Acide polyglutamique</term></keywords><keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Protéines virales</term><term>Sialidase</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Erythrocytes</term><term>Influenza A virus</term><term>Virus Attachment</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Récepteurs viraux</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Acide polyglutamique</term><term>Antienzymes</term><term>Antiviraux</term><term>Glycolipides</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Influenza A virus</term></keywords><keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr"><term>Acide polyglutamique</term><term>Antiviraux</term><term>Glycolipides</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Érythrocytes</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Erythrocytes</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Cell Line</term><term>Dose-Response Relationship, Drug</term><term>Drug Synergism</term><term>Humans</term><term>Inhibitory Concentration 50</term><term>Protein Binding</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Acide polyglutamique</term><term>Animaux</term><term>Antiviraux</term><term>Attachement viral</term><term>Concentration inhibitrice 50</term><term>Glycolipides</term><term>Humains</term><term>Liaison aux protéines</term><term>Lignée cellulaire</term><term>Relation dose-effet des médicaments</term><term>Synergie des médicaments</term><term>Virus de la grippe A</term><term>Érythrocytes</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The purpose of this study was to develop a new compound to overcome influenza epidemics and pandemics as well as drug resistance.</div></front></TEI><affiliations><list><country><li>Japon</li><li>Oman</li></country><region><li>Région de Kantō</li></region><settlement><li>Tokyo</li></settlement></list><tree><country name="Oman"><noRegion><name sortKey="Sriwilaijaroen, Nongluk" sort="Sriwilaijaroen, Nongluk" uniqKey="Sriwilaijaroen N" first="Nongluk" last="Sriwilaijaroen">Nongluk Sriwilaijaroen</name></noRegion></country><country name="Japon"><noRegion><name sortKey="Suzuki, Katsuhiko" sort="Suzuki, Katsuhiko" uniqKey="Suzuki K" first="Katsuhiko" last="Suzuki">Katsuhiko Suzuki</name></noRegion><name sortKey="Hiramatsu, Hiroaki" sort="Hiramatsu, Hiroaki" uniqKey="Hiramatsu H" first="Hiroaki" last="Hiramatsu">Hiroaki Hiramatsu</name><name sortKey="Kanie, Osamu" sort="Kanie, Osamu" uniqKey="Kanie O" first="Osamu" last="Kanie">Osamu Kanie</name><name sortKey="Suzuki, Yasuo" sort="Suzuki, Yasuo" uniqKey="Suzuki Y" first="Yasuo" last="Suzuki">Yasuo Suzuki</name><name sortKey="Takashita, Emi" sort="Takashita, Emi" uniqKey="Takashita E" first="Emi" last="Takashita">Emi Takashita</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C22 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000C22 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26169554
|texte= 6SLN-lipo PGA specifically catches (coats) human influenza virus and synergizes neuraminidase-targeting drugs for human influenza therapeutic potential.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26169554" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |